RT Journal Article
T1 Impact of the COVID-19 pandemic on interventional cardiology activity in Spain
A1 Rodriguez-Leor, Oriol
A1 Cid-Alvarez, Belen
A1 Ojeda, Soledad
A1 Martin-Moreiras, Javier
A1 Rumoroso, Jose Ramon
A1 Lopez-Palop, Ramon
A1 Serrador, Ana
A1 Cequier, Angel
A1 Romaguera, Rafael
A1 Cruz, Ignacio
A1 de Prado, Armando Perez
A1 Moreno, Raul
A1 Behalf Participants Aci-Sec Inf, 
K1 STEMI network
K1 COVID-19
K1 Primary angioplasty
K1 Survey
K1 Pandemic
AB Introduction and objectives: The COVID-19 epidemic and the declaration of the state of alarm have led to a decrease in healthcare activity in interventional cardiology units. The objective of this study is to quantify these changes in activity, with special interest in the treatment of patients with ST-segment elevation myocardial infarction (STEMI). Methods: A telematic survey of 81 centers involved in STEMI networks in the 17 autonomous communities of Spain. Information was collected on diagnostic activity, percutaneous coronary intervention (PCI), structural interventions, and PCI in STEMI on changes in the organization of STEMI networks, and on the prevalence of COVID-19 among interventional cardiologists. Data was compared for the week of February 24 through March 1 (before the outbreak) and for the week of March 16 through March 22 (during the outbreak). Results: Response has been obtained from 73 centers (90%). A very significant decrease in the number of diagnostic procedures (-56%), PCI (-48%), structural interventions (-81%) and PCI in STEMI (-40%) has been observed. A slight increase in the use of pharmacological thrombolysis has been reported, although primary angioplasty remains the leading reperfusion strategy. Up to 5% of interventional cardiologists ( 17) had COVID-19. Conclusions: An important reduction in the activity in interventional cardiology has been observed during the COVID-19 epidemic. Likewise, a great decrease has been detected in the number of patients treated in the STEMI networks, with the risk of increased morbidity and mortality that this represents. Scientific societies and health authorities have to promote that patients presenting STEMI compatible symptoms proceed with no delay to access the health system to receive reperfusion treatment in an appropriate way.
PB Permanyer publ
SN 2604-7306
YR 2020
FD 2020-04-01
LK https://hdl.handle.net/10668/25466
UL https://hdl.handle.net/10668/25466
LA en
DS RISalud
RD Apr 18, 2025